Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
dc.contributor.author | Deyab, Gia | |
dc.contributor.author | Reine, Trine M. | |
dc.contributor.author | Vuong, Tram Thu | |
dc.contributor.author | Jenssen, Trond Geir | |
dc.contributor.author | Hjeltnes, Gunnbjørg | |
dc.contributor.author | Agewall, Stefan | |
dc.contributor.author | Mikkelsen, Knut | |
dc.contributor.author | Førre, Øystein | |
dc.contributor.author | Fagerland, Morten | |
dc.contributor.author | Kolset, Svein Olav | |
dc.contributor.author | Hollan, Ivana | |
dc.date.accessioned | 2022-03-01T12:47:30Z | |
dc.date.available | 2022-03-01T12:47:30Z | |
dc.date.created | 2022-01-10T15:10:55Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | PLOS ONE. 2021, 16 (7), e0253247-?. | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://hdl.handle.net/11250/2982104 | |
dc.language.iso | eng | en_US |
dc.publisher | PLoS | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | e0253247-? | en_US |
dc.source.volume | 16 | en_US |
dc.source.journal | PLOS ONE | en_US |
dc.source.issue | 7 | en_US |
dc.identifier.doi | 10.1371/journal.pone.0253247 | |
dc.identifier.cristin | 1977717 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |